Pediatr. praxi. 2009;10(5):306-310

Tick-borne encephalitis

MUDr. Václav Chmelík1,2
1 Jihočeská univerzita, Fakulta zdravotně sociální
2 Infekční oddělení Nemocnice České Budějovice a. s

Tick-borne encephalitis (TBE) as a disease of the central nervous system is endemic in many regions of Europe and Asia. There is increasing

number of hot spot areas in all parts of the Czech Republic, probably due to climate changes. The outdoor activities of people in natural

foci are essential for infection. Most of the patients have biphasic course of disease. In the second phase, the central nervous system is

affected: meningitis, more serious encephalitis and encephalomyelitis are observed. Encephalitis and encephalomyelitis have temporary

or long lasting sequelae very profoundly changing the quality of life. More serious diseases are observed in the elderly. TBE in childhood

and youngsters tends to be mild, but very serious or event fatal cases have been described. There is no causal therapy, symptomatic

treatment has to be very intensive in some patients. TBE vaccination is considered an effective prophylaxis to prevent the disease and

has been successfully implemented in the endemic countries. Two TBE vaccines are available in most European countries. Both vaccines

are safe and efficacious. In some parts of the Czech Republic the vaccination coverage has increased in childhood and younger people.

In such regions is number of cases in childhood decreasing.

Keywords: tick borne encephalitis, epidemiology, clinical course, vaccination.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chmelík V. Tick-borne encephalitis. Pediatr. praxi. 2009;10(5):306-310.
Download citation

References

  1. Heinz FX. Molecular aspects of TBE virus research. Vaccine 2003; 21: (S1/3-S1/10). Go to original source... Go to PubMed...
  2. Kaiser R. The clinical and epidemiological profile of tickborne encephalitis in Southern Germany 1994-1998. Brain 1999; 122: 2067-2078. Go to original source... Go to PubMed...
  3. Haglund M, Günther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 2003; 21(Suppl.1): 11-18. Go to original source... Go to PubMed...
  4. Kunze U, Asokliene L, Busse A, et al. Tick borne encephalitis in childhood: conference report and consensus of the International Scientific Working Group on tick-borne encephalitis (ISW-TBE). Vaccine 2004; 23: 729-731. Go to original source...
  5. Kunze U, Baumbach U, Bretschneider R, et al. The Golden Agers and Tick Borne Encephalitis. Vaccine 2006; 24. Go to original source...
  6. Chmelik V, Petr P, Slamova I, et al. Quality of Life after Tick Borne Encephalitis. Clinical Microbiology and Infection 2004; 10(Suppl. 3): 397.
  7. Luňáčková L, Chmelík V, Šípová I, et al. Epidemiologické sledování klíšťové encefalitidy v Jižních Čechách - lokalita Římov. Epidemiologie mikrobiologie imunologie 2003: 52.
  8. Zent O, Broker M. Tick-borne encephalitis vaccines: past and present. Expert Rev Vaccines 2005; 4: 747-755. Go to original source... Go to PubMed...
  9. Kunz C. Vaccination against TBE in Austria: the succes story continues. Int J Med Microbiol 2002; 291: 56-57. Go to original source... Go to PubMed...
  10. Handouts of 9th ISW TBE 2007 Vienna, 25-26 Jan 2007.
  11. Bröker M, Schöndorf I. Are tick-borne encephalitis vaccines interchangeable? Expert Rev Vaccines 2006; 5: 461-466. Go to original source... Go to PubMed...
  12. Chmelik V, Lunackova J, Sipova I, et al. The Rimov TBE vaccination project. International Symposium for Tick Borne Diseases. Berlin, 2003; 3: 11-12.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.